Ro-52 antibodies are described in up to 60% of patients with Anti MDA-5 DM and may pose a greater risk for RP ILD and mortality in these patients.12 In our case, the association of Ro52 antibody with Anti MDA-5 antibody was an indicator of poor prognosis. Here, TRIM21 is linked to interstitial lung disease.